This activity seeks to review innovative clinical trials in the treatment of head and neck cancers from a radiation, surgical and systemic therapy perspective. These trials have novel translational components that may spearhead the next generation of novel clinical trials in these diseases.

This session reviews the latest science in the field of head and neck cancer.

This session will review the latest science in the field of head and neck cancer.

This panel addresses the emerging evidence transforming the care of advanced head and neck cutaneous malignancy patients, from neoadjuvant and adjuvant immunotherapies to response adaptive surgery and modern approaches to radiation treatment and sentinel node biopsy.

We are in an era of abundant technological innovation. Numerous emerging tools may allow clinicians to evaluate the status of cancer and make clinical decisions faster and less invasively.

This presentation provides a comprehensive critique of the clinical and preclinical evidence for neoadjuvant immunotherapy. Emphasis is placed on sharpening the definition of immunotherapy, identifying its multi-compartmental effects, and its off-target effects.

Dr. Carmen Guerra presents on the persistent racial and ethnic disparities that exist in patient access to clinical trials in head and neck oncology.

There are many ongoing advances in patient safety in the context of radiation therapy delivery, clinical research on treatment options, and advanced techniques in radiotherapy delivery.

It is imperative that our HNSCC medical care team across specialties professional remain current in the state-of-the-art techniques (Knowledge).

This session reviews head and neck cancers from a patient perspective.